Skip to content

Nis Register Study Comparing Seroquel and Seroquel Prolong

A Local Non Interventional Retrospective Register Study of the Current Clinical Treatment Practices and the Number of Hospitalization Days With Seroquel or Seroquel Prolong.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00965536
Enrollment
200
Registered
2009-08-25
Start date
2009-08-31
Completion date
2010-12-31
Last updated
2011-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparing Hospitalisation Time With Seroquel and Seroquel Prolong

Keywords

Schizophrenia, Bipolar Disorder, Manic Disorder, Register study, Quetiapine, Quetiapine Prolong, Seroquel, Seroquel Prolong, Seroquel XR, In-patient

Brief summary

The general aim of this non interventional study is to clarify what are the current clinical treatment practices of Quetiapine Immediate Release and Quetiapine Extended Release. The primary objectives of the study are:1.To collect information on the used Quetiapine Immediate Release or Quetiapine Extended Release medication 2.To collect information on duration and number of hospitalisation days 3.Change of GAF points

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Medication: Seroquel or Seroquel Prolong * Diagnosis: F20-F29 or F30-F31 (ICD-10) * In-patient

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Hospitalisation time2008-2010
Treatment practice2008-2010

Secondary

MeasureTime frame
Primary diagnosis2008-2010
Medication at the end of hospitalisation2008-2010
GAF rating points2008-2010

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026